These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 11959796)
1. Effects of chronic administration of the novel endothelin antagonist J-104132 on endothelial dysfunction in streptozotocin-induced diabetic rat. Kanie N; Kamata K Br J Pharmacol; 2002 Apr; 135(8):1935-42. PubMed ID: 11959796 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats. Kobayashi T; Matsumoto T; Kamata K Br J Pharmacol; 2000 Sep; 131(2):231-8. PubMed ID: 10991915 [TBL] [Abstract][Full Text] [Related]
3. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats. Majithiya JB; Paramar AN; Balaraman R Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458 [TBL] [Abstract][Full Text] [Related]
4. Effect of insulin treatment on smooth muscle contractility and endothelium-dependent relaxation in rat aortae from established STZ-induced diabetes. Kobayashi T; Kamata K Br J Pharmacol; 1999 Jun; 127(4):835-42. PubMed ID: 10433489 [TBL] [Abstract][Full Text] [Related]
6. Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats. Kobayashi T; Kamata K Atherosclerosis; 2001 Apr; 155(2):313-20. PubMed ID: 11254901 [TBL] [Abstract][Full Text] [Related]
7. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin. Wang C; Li J; Lv X; Zhang M; Song Y; Chen L; Liu Y Eur J Pharmacol; 2009 Oct; 620(1-3):131-7. PubMed ID: 19686728 [TBL] [Abstract][Full Text] [Related]
8. Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus. Schäfer A; Fraccarollo D; Pförtsch S; Flierl U; Vogt C; Pfrang J; Kobsar A; Renné T; Eigenthaler M; Ertl G; Bauersachs J Br J Pharmacol; 2008 Mar; 153(5):886-93. PubMed ID: 17891166 [TBL] [Abstract][Full Text] [Related]
9. 3',4'-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta. Woodman OL; Malakul W Life Sci; 2009 Jul; 85(1-2):54-9. PubMed ID: 19409910 [TBL] [Abstract][Full Text] [Related]
10. Carvedilol ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats. Fu GS; Huang H; Chen F; Wang HP; Qian LB; Ke XY; Xia Q Eur J Pharmacol; 2007 Jul; 567(3):223-30. PubMed ID: 17559835 [TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with taurine ameliorates diabetes-induced dysfunction of nitric oxide-mediated neurogenic and endothelium-dependent corpus cavernosum relaxation in rats. Dalaklioglu S; Kuscu N; Celik-Ozenci C; Bayram Z; Nacitarhan C; Ozdem SS Fundam Clin Pharmacol; 2014 Aug; 28(4):394-404. PubMed ID: 23848484 [TBL] [Abstract][Full Text] [Related]
13. Relationship between peroxisome proliferator-activated receptors (PPAR alpha and PPAR gamma) and endothelium-dependent relaxation in streptozotocin-induced diabetic rats. Kanie N; Matsumoto T; Kobayashi T; Kamata K Br J Pharmacol; 2003 Sep; 140(1):23-32. PubMed ID: 12967931 [TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction, macrophage infiltration and NADPH oxidase-dependent superoxide production were attenuated by erythropoietin in streptozotocin-induced diabetic rat aorta. Wang J; Toba H; Morita Y; Nakashima K; Noda K; Tian W; Kobara M; Nakata T Pharmacology; 2013; 91(1-2):48-58. PubMed ID: 23154660 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy with losartan and L-carnitine protects against endothelial dysfunction of streptozotocin-induced diabetic rats. Sleem M; Taye A; El-Moselhy MA; Mangoura SA Eur J Pharmacol; 2014 Dec; 744():10-7. PubMed ID: 25281836 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-2 protects against endothelial dysfunction induced by high glucose levels in rats. Qian LB; Wang HP; Qiu WL; Huang H; Bruce IC; Xia Q Vascul Pharmacol; 2006 Dec; 45(6):374-82. PubMed ID: 16837248 [TBL] [Abstract][Full Text] [Related]
19. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats. Ceylan-Isik A; Hünkar T; Aşan E; Kaymaz F; Ari N; Söylemezoğlu T; Renda N; Soncul H; Bali M; Karasu C; J Pharm Pharmacol; 2007 Dec; 59(12):1629-41. PubMed ID: 18053324 [TBL] [Abstract][Full Text] [Related]
20. Sildenafil improves diabetic vascular activity through suppressing endothelin receptor A, iNOS and NADPH oxidase which is comparable with the endothelin receptor antagonist CPU0213 in STZ-injected rats. Luo L; Dai DZ; Cheng YS; Zhang Q; Yuan WJ; Dai Y J Pharm Pharmacol; 2011 Jul; 63(7):943-51. PubMed ID: 21635260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]